Stocks Health care SYK
NYSE · Health careStryker Corp (SYK)
Stryker Corp brought in $25.8B of revenue over the twelve months to June 30, 2026, up 8.5% from a year earlier. Net income was $3.7B, a net margin of 14.4%. Operating cash flow minus capital spending left $4.3B of free cash flow in fiscal 2025. At June 30, 2026 it held $3.4B in cash against $14.2B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 31, 2026.
Key facts about Stryker Corp
- Net worth
- Stryker Corp has a market value (market cap) of $106.4B at the latest share price, and shareholders' equity of $24B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $25.1B (+11.2% year on year), with net income of $3.2B. Over the 12 months to June 30, 2026: revenue $25.8B, net income $3.7B.
- Cash flow
- In fiscal 2025 operations brought in $5B of cash; after $761M of capital spending, free cash flow was $4.3B.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on July 31, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Stryker Corp's next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
What Stryker Corp does
Stryker develops and manufactures medical technologies and equipment. Its products include orthopedic implants for joint replacement, surgical equipment, surgical navigation systems, neurotechnology devices, hospital beds, and patient handling equipment. Hospitals, clinics, and emergency medical services buy these products to treat patients and support clinical workflows. Its shares trade on NYSE under the ticker SYK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $25.1B | $3.2B | $8.40 | $4.3B |
| 2024 | $22.6B | $3B | $7.76 | $3.5B |
| 2023 | $20.5B | $3.2B | $8.25 | $3.1B |
| 2022 | $18.4B | $2.4B | $6.17 | $2B |
| 2021 | $17.1B | $2B | $5.21 | $2.7B |
| 2020 | $14.4B | $1.6B | $4.20 | $2.8B |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where SYK ranks in Health care
Dividends
It paid out $1.3B in cash dividends, 40% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2025 | n/a | $1.3B | 40% |
| 2024 | n/a | $1.2B | 41% |
| 2023 | n/a | $1.1B | 36% |
| 2022 | n/a | $1.1B | 45% |
| 2021 | n/a | $950M | 48% |
| 2020 | n/a | $863M | 54% |
Latest SEC filings
What Stryker Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 6, 2026Executive or director change8-KStryker announced that CEO Kevin Lobo will transition to Executive Chair and Spencer Stiles will become CEO on January 1, 2027.
- July 31, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 9.4% to $6.6B versus the same quarter last year; diluted EPS $3.30 versus $2.29.
- July 30, 2026
- June 26, 2026Other event 8-K
- May 22, 2026
- May 20, 2026
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 2.6% to $6B versus the same quarter last year; diluted EPS $1.93 versus $1.69.
- May 8, 2026
- April 30, 2026
- April 30, 2026Passive stake (5% or more) SCHEDULE 13G
What is SYK worth? A DCF from its reported cash flow
Insider trades
What the people running Stryker Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $118.2M worth of shares in the last 90 days and bought none on the open market.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 24, 2026 | Wells Preston WendellVP, Chief Financial Officer | Other change | 109 | - |
| September 22, 2026 | Wells Preston WendellVP, Chief Financial Officer | Other change | 962 | - |
| August 21, 2026 | Crotty Dylan BramGroup President | Soldindirect | 441 | $144.9K |
| August 19, 2026 | Stryker Ronda EDirector | Soldindirect | 40 | $13.3K |
| August 19, 2026 | Stryker Ronda EDirector | Soldindirect | 440 | $146.6K |
| August 19, 2026 | Stryker Ronda EDirector | Soldindirect | 200 | $66.8K |
| August 19, 2026 | Stryker Ronda EDirector | Soldindirect | 80 | $26.8K |
| August 19, 2026 | Stryker Ronda EDirector | Soldindirect | 320 | $107.8K |
Who owns SYK
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 6.73% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 2,257 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 27,414,742 | -187,307 |
| Vanguard Capital Management LLC | 22,536,843 | +153,662 |
| Jpmorgan Chase & Co | 17,260,943 | +1,664,046 |
| State Street Corp | 15,532,565 | +183,400 |
| Greenleaf Trust | 15,228,545 | -709,525 |
| Vanguard Portfolio Management LLC | 8,173,167 | -161,077 |
| Wellington Management Group Llp | 8,167,185 | +45,478 |
| Geode Capital Management, LLC | 7,819,802 | +71,508 |
| Morgan Stanley | 5,960,732 | -336,823 |
| Alliancebernstein L.P. | 4,927,021 | -1,125,968 |
| Norges Bank | 4,892,615 | new |
| Bank of America Corp | 4,460,311 | +346,554 |
| Bank of New York Mellon Corp | 3,548,516 | -403,885 |
| Royal Bank of Canada | 3,475,558 | +202,326 |
| Northern Trust Corp | 3,326,549 | +23,065 |
| Arrowstreet Capital, Limited Partnership | 3,282,207 | +1,726,569 |
| Ameriprise Financial Inc | 3,272,554 | +1,865,859 |
| First Western Trust Bank | 3,017,349 | -2,104 |
| Fundsmith LLP | 2,913,833 | -147,583 |
| Franklin Resources Inc | 2,787,785 | +1,731 |
Insiders
20 insiders reported holding 2,754,025 shares in total, about $763.8M at the last price.
| Holder | Shares |
|---|---|
| Stryker Ronda EDirector | 2,252,6972,251,375 held indirectly |
| Lobo KevinChair and CEO, Director | 222,231 |
| Pierce James AndrewGroup President | 81,582713 held indirectly |
| Stiles Spencer SPresident and COO | 76,027 |
| Silvernail Andrew KDirector | 18,465 |
| Menon VijuGroup President | 17,382 |
| Fink M KathrynVP, Chief HR Officer | 13,204177 held indirectly |
| Crotty Dylan BramGroup President | 11,5766,102 held indirectly |
| Fletcher Robert SVP, Chief Legal Officer | 10,488 |
| Brainerd Mary KDirector | 7,921131 held indirectly |
Questions about SYK
What does Stryker Corp do?
Stryker develops and manufactures medical technologies and equipment. Its products include orthopedic implants for joint replacement, surgical equipment, surgical navigation systems, neurotechnology devices, hospital beds, and patient handling equipment. Hospitals, clinics, and emergency medical services buy these products to treat patients and support clinical workflows. Its shares trade on NYSE under the ticker SYK.
What is Stryker Corp's net worth?
Stryker Corp has a market value (market cap) of $106.4B at the latest share price, and shareholders' equity of $24B on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Stryker Corp profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $3.7B on revenue of $25.8B, a net margin of 14.4%.
How much revenue does Stryker Corp make?
Over the twelve months to June 30, 2026 Stryker Corp reported revenue of $25.8B. That is 8.5% more than a year earlier.
When did Stryker Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 31, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the executive or director change from October 6, 2026.
When is Stryker Corp's next earnings report?
Stryker Corp's next report is expected around October 29, 2026. That is an estimate from its filing rhythm, not a date the company has announced.
Theses that mention SYK
Similar companies
Compare SYK with
Follow SYK
Get an email when Stryker Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Stryker Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.